Showing results (171-180 of 652) with videos related to
Sort By:
Pageof 66
Acta Gastroenterologica Latinoamericana|May 5, 2011
[Esophageal tuberculosis: case report and review of the literature]Ariana Sala Lozano, Natalia Leibovich, Gonzalo Souto, et al.Frontiers in Immunology|April 12, 2024
Evaluation of tumor response to immune checkpoint inhibitors by a 3D immunotumoroid modelAbdulmohammad Pezeshki, John C Cheville, Angela B Florio, et al.Pathobiology : Journal of Immunopathology, Molecular and Cellular Biology|January 1, 1990
Reactivity of human tissues with monoclonal antibodies to myeloid activation and differentiation antigens. An immunohistochemical studyA E Koch, J C Burrows, R Marder, et al.Mayo Clinic Proceedings|April 10, 2007
Stratification of patient risk based on prostate-specific antigen doubling time after radical retropubic prostatectomyMatthew K Tollefson, Jeffrey M Slezak, Bradley C Leibovich, et al.The Journal of Urology|May 8, 2000
Outcome prediction with p53 immunostaining after radical prostatectomy in patients with locally advanced prostate cancerB C Leibovich, L Cheng, A L Weaver, et al.The Journal of Urology|August 12, 2005
Complications of contemporary open nephron sparing surgery: a single institution experienceR Houston Thompson, Bradley C Leibovich, Christine M Lohse, et al.Journal of Cardiovascular Electrophysiology|September 6, 2002
Exclusion of fluoroscopy during ablation treatment of right accessory pathway in childrenFabrizio Drago, Massimo Stefano Silvetti, Alfredo Di Pino, et al.Journal of the National Cancer Institute|February 1, 1979
Surface charge characteristics of cells from malignant cell lines and normal cell lines of the human hematopoietic systemY Marikovsky, H Ben-Bassat, S J Leibovich, et al.The Journal of Urology|January 13, 2006
Long-term prognostic significance of primary Gleason pattern in patients with Gleason score 7 prostate cancer: impact on prostate cancer specific survivalMatthew K Tollefson, Bradley C Leibovich, Jeffrey M Slezak, et al.Agents and Actions|November 1, 1991
Thiol-containing compounds inhibit the production of monocyte/macrophage-derived angiogenic activityA E Koch, J C Burrows, P J Polverini, et al.Pageof 66